Nanozymes as Enzyme Inhibitors

Nanozymes as Enzyme Inhibitors

Yaling Huang,1 Jian Jiang,1 Yanqiu Wang,1 Jie Chen,1 Juqun Xi1,2 1Institute of Translational Medicine, Department of Pharmacology, School of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, People’s Republic of China; 2Jiangsu Key Laboratory of Integrated Traditional Chinese and W...

Full description

Bibliographic Details
Main Authors:	Huang Y, Jiang J, Wang Y, Chen J, Xi J
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	International Journal of Nanomedicine
Subjects:	nanozyme r-chymotrypsin inhibitor β-galactosidase inhibitor β-lactamase inhibitor mitochondrial f0f1-atpase inhibitor
Online Access:	https://www.dovepress.com/nanozymes-as-enzyme-inhibitors-peer-reviewed-article-IJN

Similar Items

Production of β-Lactamase Inhibitors by Streptomyces Species
by: Daniela de Araújo Viana Marques, et al.
Published: (2018-07-01)

Screening and Purification of a Chymotrypsin Inhibitor from Entrolobium Saman Seeds
by: Maher Ali. Maqtari, et al.
Published: (2010-12-01)

Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors
by: Yi-Lin Zhang, et al.
Published: (2020-02-01)

Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in Enterobacterales
by: Jun-ichi Wachino, et al.
Published: (2024-03-01)

In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria
by: Cécile Emeraud, et al.
Published: (2023-09-01)

MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates
by: Andrei Zidaru, et al.
Published: (2020-12-01)

L-Cysteine as an Irreversible Inhibitor of the Peroxidase-Mimic Catalytic Activity of 2-Dimensional Ni-Based Nanozymes
by: Piyumi Dinusha Liyanage, et al.
Published: (2021-05-01)

Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme
by: Rahma Ben Abderrazek, et al.
Published: (2024-03-01)

Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
by: Annelien Everaert, et al.
Published: (2016-11-01)

The structure of F1-ATPase from Saccharomyces cerevisiae inhibited by its regulatory protein IF1
by: Graham C. Robinson, et al.
Published: (2013-01-01)

Synthesis and enzyme-based evaluation of analogues L-tyrosine thiol carboxylic acid inhibitor of metallo-β-lactamase IMP-1
by: Omid Khalili Arjomandi, et al.
Published: (2019-01-01)

Intestinal Exposure to Food-Derived Protease Inhibitors: Digestion Physiology- and Gut Health-Related Effects
by: Anna Kårlund, et al.
Published: (2021-08-01)

Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization
by: Nabeela Farhat, et al.
Published: (2022-10-01)

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022-04-01)

Biochemical exploration of β-lactamase inhibitors
by: Varshaa Arer, et al.
Published: (2023-01-01)

Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases
by: Jung Hun Lee, et al.
Published: (2024-12-01)

Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria
by: Song Zhang, et al.
Published: (2024-03-01)

Comparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli
by: Smita Sood
Published: (2013-02-01)

New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams
by: Juan C. Vázquez-Ucha, et al.
Published: (2020-12-01)

Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase
by: Roberto Pestana-Nobles, et al.
Published: (2022-01-01)

β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014-05-01)

Susceptibility to Imipenem/Relebactam of Pseudomonas aeruginosa and Acinetobacter baumannii Isolates from Chinese Intra-Abdominal, Respiratory and Urinary Tract Infections: SMART 2015 to 2018
by: Zhang H, et al.
Published: (2021-08-01)

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
by: Davide Carcione, et al.
Published: (2021-08-01)

Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis
by: L Davies Forsman, et al.
Published: (2015-01-01)

Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening
by: Barbara Garofalo, et al.
Published: (2021-06-01)

Effect of Inhibitors β-Lactamase on Recovery Effectiveness of Some β-Lactam Antibioticis Against Pseudomonas Aeruginosa
by: Adnan N Al-Azawy, et al.
Published: (2019-11-01)

Effect of Inhibitors β-Lactamase on Recovery Effectiveness of Some β-Lactam Antibioticis Against Pseudomonas Aeruginosa
by: Adnan N Al-Azawy, et al.
Published: (2019-11-01)

Synthesis and evaluation of 1, 2, 3-triazole benzoate derivatives for inhibition of serine β-lactamases in extensively drug resistant pathogenic E. coli strains
by: Harshal S. Oman, et al.
Published: (2023-12-01)

Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms
by: Gabriele Bianco, et al.
Published: (2022-11-01)

Drug Discovery in the Field of β-Lactams: An Academic Perspective
by: Lian M. C. Jacobs, et al.
Published: (2024-01-01)

MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo-β-Lactamase Inhibitors
by: Zishuo Cheng, et al.
Published: (2020-03-01)

In Vitro Activity of a Novel Siderophore-Cephalosporin, GT-1 and Serine-Type β-Lactamase Inhibitor, GT-055, against <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i> and <i>Acinetobacter</i> spp. Panel Strains
by: Le Phuong Nguyen, et al.
Published: (2020-05-01)

Molecular Basis of Bicyclic Boronate β-Lactamase Inhibitors of Ultrabroad Efficacy – Insights From Molecular Dynamics Simulation Studies
by: Emilio Lence, et al.
Published: (2021-08-01)

Clinical characteristics and factors related to antibiotic-associated diarrhea in elderly patients with pneumonia: a retrospective cohort study
by: Yoko Takedani, et al.
Published: (2021-05-01)

Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens
by: Corneliu Ovidiu Vrancianu, et al.
Published: (2020-11-01)

THE EUROPEAN MEDICINES AGENCY APPROVED THE NEW ANTIBACTERIAL DRUGS – RESPONSE TO THE 2017 WHO REPORT ON THE GLOBAL PROBLEM OF MULTI-DRUG RESISTANCE
by: Joanna Krajewska, et al.
Published: (2021-12-01)

In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing <i>Klebsiella pneumoniae</i>: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
by: Snehal Palwe, et al.
Published: (2021-10-01)

Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation
by: Mariana Castanheira, et al.
Published: (2023-10-01)

Structures of FOX-4 Cephamycinase in Complex with Transition-State Analog Inhibitors
by: Scott T. Lefurgy, et al.
Published: (2020-04-01)

β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward
by: Lekshmi Narendrakumar, et al.
Published: (2023-03-01)